Literature DB >> 17070333

Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction.

Ridwan Shabsigh1, Allen D Seftel, Raymond C Rosen, Hartmut Porst, Sanjeev Ahuja, Michael C Deeley, Carmen S Garcia, François Giuliano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17070333     DOI： 10.1016/j.urology.2006.05.009

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  8 in total

Review 1.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 2.  The use of phosphodiesterase 5 inhibitors with concomitant medications.

Authors:  G Corona; E Razzoli; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

3.  Longitudinal evaluation of sexual function in a male cohort: the Olmsted county study of urinary symptoms and health status among men.

Authors:  Naomi M Gades; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; Michael M Lieber; Ajay Nehra; Cynthia J Girman; Steven J Jacobsen
Journal:  J Sex Med       Date:  2009-06-29       Impact factor: 3.802

Review 4.  Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment.

Authors:  Cem Akbal; Ilker Tinay; Ferruh Simşek; Levent N Turkeri
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

5.  Conformational variations of both phosphodiesterase-5 and inhibitors provide the structural basis for the physiological effects of vardenafil and sildenafil.

Authors:  Huanchen Wang; Mengchun Ye; Howard Robinson; Sharron H Francis; Hengming Ke
Journal:  Mol Pharmacol       Date:  2007-10-24       Impact factor: 4.436

6.  Chronic low dosing of phosphodiesterase type 5 inhibitor for erectile dysfunction.

Authors:  Hyun Hwan Sung; Sung Won Lee
Journal:  Korean J Urol       Date:  2012-06-19

Review 7.  The devil is in the details: an analysis of the subtleties between phosphodiesterase inhibitors for erectile dysfunction.

Authors:  L I Smith-Harrison; Abhishek Patel; Ryan P Smith
Journal:  Transl Androl Urol       Date:  2016-04

8.  Comparative efficacy of tamsulosin versus tadalafil as medical expulsive therapy for distal ureteric stones.

Authors:  Suresh Kumar Goyal; Vikash Singh; Himanshu Pandey; Mahaveer Kumar Chhabra; Satinder Pal Aggarwal; Amilal Bhat
Journal:  Urol Ann       Date:  2018 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.